TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 2 | 0 | -2 | -9 | -13 | -2 | -11 | -7 |
| S | %wins | 100 | 100 | 50 | 100 | 50 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/15/21 16:26 | 9/13/21 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lee Kenneth B Jr | NC | D | S.d | -92 | 15.35 | 0 | -6 | -20 | 24 | D | |||||||||||||||
3/7/14 16:17 | 3/6/14 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lee Kenneth B Jr | NC | D | S.d | -161 | 12.69 | 14 | -13 | -55 | 10 | D | 162 | 901 | 85 | 102 | 1 | 23 | -4 | -1 | 0 | -4 | -19 | -7 | 11 | -11 | |
9/18/12 17:00 | 9/14/12 | POZN | Pozen Inc /nc | Health | Drug | Pharmaceutical Preparations | Lee Kenneth B Jr | NC | D | S.d | -103 | 6.49 | 1 | -16 | -44 | 20 | D | -2 | 129 | 33 | -10 | 0 | -3 | -1 | 6 | 0 | 0 | 1 | -19 | -15 | -10 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |